
Harnessing Hope: Genetic Testing for Hyperuricemic Nephropathy, Familial Juvenile Type 3
Genetic testing for HNFJ3 provides precise diagnosis, early detection, and personalized treatment, improving outcomes for those with this rare kidney disorder.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Genetic testing for HNFJ3 provides precise diagnosis, early detection, and personalized treatment, improving outcomes for those with this rare kidney disorder.

Explore how genetic testing empowers early diagnosis and personalized management of Hypotonia-Failure to Thrive-Microcephaly Syndrome, improving outcomes and family planning.

Explore the genetic basis of ICF2 syndrome, its causes, and diagnosis with genetic testing to uncover novel mutations in the ZBTB24 gene for better treatment.

Explore how genetic testing can identify insomnia risk factors, personalize treatments, and enhance drug efficacy, paving the way for improved sleep solutions.

Explore how genetic testing aids in diagnosing Intellectual Disability, Autosomal Dominant 10. Learn about early intervention, family planning, and personalized care.


Explore how genetic testing for Intellectual Disability, Autosomal Dominant 2 (IDAD2), using CHAMP1 gene insights, aids early diagnosis, treatment, and family planning.

Explore how genetic testing, especially whole exome sequencing, enhances IDAD6 diagnosis and treatment, uncovering novel ZBTB18 variants for personalized care.